Salvador, Ashraf O.
HRN: 22-50-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/30/2023
02/08/2023
IV
65
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes